Ba. Fischer et al., Tumor necrosis factor-alpha induced DNA cleavage in human articular chondrocytes may involve multiple endonucleolytic activities during apoptosis, MICROSC RES, 50(3), 2000, pp. 236-242
Apoptosis has been documented in chondrocytes both in the growth plates of
young, healthy cartilages and in osteoarthritic cartilages; little, however
, is known about apoptosis in chondrocytes of normal adult articular cartil
age. For the current study, apoptosis in adult chondrocytes was evaluated b
y labeling DNA fragments using the ISEL in situ end labeling of 3'-recessed
strand breaks) or TUNEL (5'-recessed or blunt-ended strand breaks with ter
minal deoxynucleotidyl transferase-mediated nick end labeling) techniques i
n primary cultures of chondrocytes in monolayer. Apoptosis was induced in t
he chondrocytes by either Tumor Necrosis Factor alpha (TNF alpha), Interleu
kin 1-beta (IL-1 beta), or anti-Fas antibody but only after 48 hours in cul
ture. At 4 and 24 hours, there was no detectable DNA fragmentation. With TN
F alpha, IL1 beta, and anti-Fas antibody, chondrocytes show evidence of at
least two types of DNA strand breaks within the same cell las assessed by s
imultaneous labeling with ISEL and TUNEL). Therefore, some pathways leading
to apoptosis in chondrocytes appear to involve more than one type of endon
uclease activity. When the chondrocytes were cultured as explants with the
articular matrix intact lex vivo), neither IL-1 beta, TNF alpha, the anti-F
as antibody, nor fibronectin fragments were able to induce apoptosis in the
chondrocytes. In normal human adult cartilage that was untreated and uncul
tured tin situ), DNA fragmentation was undetectable; however, a significant
number of chondrocytes in osteoarthritic cartilage did contain strand brea
ks. These data suggest that apoptosis occurs in chondrocytes in which the m
atrix has been disrupted experimentally or destroyed by the osteoarthritic
disease process. The results of these studies suggest that the ECM may be a
n essential survival factor for chondrocytes. (C) 2000 Wiley-Liss, Inc.